Bioregenx reported total assets of $0.34M and total liabilities of $4.87M for the quarter ended Mar 2026, down 30.2% year over year. This balance sheet covers 18 quarters of results from Dec 2021 through Mar 2026, standardized by Business Quant from the company’s SEC filings.
| Balance Sheet | Dec2021 | Mar2022 | Jun2022 | Sep2022 | Dec2022 | Mar2023 | Jun2023 | Sep2023 | Dec2023 | Mar2024 | Jun2024 | Sep2024 | Dec2024 | Mar2025 | Jun2025 | Sep2025 | Dec2025 | Mar2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||||||||
| Current Assets | ||||||||||||||||||
| Cash & EquivalentsCash & Equiv. | 0.02M | 0.00M | 0.00M | 0.00M | 676.00 | 758.00 | 0.13M | 0.11M | 0.06M | 0.07M | 0.06M | 0.08M | 0.05M | 0.05M | 0.07M | 0.05M | ||
| Cash & Current Investments | 0.02M | 0.00M | 0.00M | 0.00M | 676.00 | 758.00 | 0.13M | 0.11M | 0.06M | 0.07M | 0.06M | 0.08M | 0.05M | 0.05M | 0.07M | 0.05M | ||
| Receivables - NetNet Receivables | 0.10M | 0.10M | 0.01M | 0.02M | 0.01M | 0.01M | 0.02M | 0.06M | 0.04M | 0.02M | ||||||||
| Receivables - OtherOther Receivables | 0.19M | |||||||||||||||||
| Receivables | 0.10M | 0.10M | 0.01M | 0.02M | 0.20M | 0.01M | 0.02M | 0.06M | 0.04M | 0.02M | ||||||||
| Inventory | 0.22M | 0.21M | 0.14M | 0.16M | 0.11M | 0.14M | 0.13M | 0.11M | 0.11M | 0.09M | ||||||||
| Prepaid Assets | 0.21M | 0.21M | 0.15M | 0.11M | 0.12M | 0.12M | 0.06M | 0.05M | 0.05M | 0.04M | 0.03M | |||||||
| Current Assets | 0.02M | 676.00 | 758.00 | 0.65M | 0.49M | 0.33M | 0.37M | 0.31M | 0.29M | 0.25M | 0.27M | 0.25M | 0.19M | |||||
| Non-Current Assets | ||||||||||||||||||
| Property, Plant & Equipment (Net)PP&E (Net) | 0.01M | 0.23M | 0.23M | 0.21M | 0.20M | 0.19M | 0.18M | 0.17M | 0.16M | 0.15M | ||||||||
| Long-Term Investments | 0.06M | 0.02M | 0.04M | 0.05M | 200.00 | 100.00 | ||||||||||||
| Goodwill | 7.11M | 7.11M | 7.11M | |||||||||||||||
| Intangibles | 0.04M | 0.04M | 0.04M | 0.03M | 0.03M | 0.05M | 11.29M | 11.29M | 11.29M | 0.72M | 0.72M | |||||||
| Goodwill & Intangibles | 0.04M | 0.04M | 0.04M | 0.03M | 0.03M | 0.05M | 18.40M | 18.40M | 18.40M | 0.72M | 0.72M | |||||||
| Long-Term Deferred Tax | 0.59M | 0.61M | 0.71M | 1.37M | 1.40M | |||||||||||||
| Other Non-Current Assets | 0.15M | |||||||||||||||||
| Non-Current Assets | 0.10M | 0.06M | 0.08M | 0.09M | 0.03M | 0.03M | 18.13M | 17.56M | 16.99M | 0.20M | 0.19M | 0.90M | 0.89M | 0.16M | 0.15M | |||
| Assets | 0.13M | 0.06M | 0.08M | 0.09M | 0.03M | 0.87M | 18.62M | 17.89M | 17.36M | 0.51M | 0.48M | 1.15M | 1.17M | 0.41M | 0.34M | |||
| Liabilities | ||||||||||||||||||
| Current Liabilities | ||||||||||||||||||
| Accounts Payables | 0.24M | 0.37M | 0.43M | 0.49M | 0.43M | 0.49M | 0.57M | 0.46M | 0.62M | 0.70M | ||||||||
| Notes Payables | 0.04M | 0.01M | 0.01M | 0.01M | 0.53M | 0.96M | 1.14M | 1.14M | 0.17M | 0.17M | ||||||||
| Payables | 0.04M | 0.01M | 0.01M | 0.01M | 0.77M | 1.33M | 0.43M | 0.49M | 1.57M | 1.63M | 0.57M | 0.46M | 0.78M | 0.87M | ||||
| Accumulated Expenses | 0.01M | 0.02M | 0.02M | 0.02M | 0.03M | 0.35M | 0.36M | 0.40M | 0.43M | 0.45M | 0.51M | 0.41M | 0.38M | 0.43M | 0.39M | |||
| Other Accumulated Expenses | 0.20M | 0.20M | ||||||||||||||||
| Short term Debt | 0.00M | 0.00M | 0.00M | 0.00M | 0.20M | 0.38M | 0.85M | 0.85M | 0.88M | 0.88M | 0.88M | 0.97M | 1.04M | 1.00M | 0.95M | |||
| Current Deferred Revenue | 0.63M | 0.35M | 0.34M | 0.20M | 0.17M | 0.20M | 0.19M | 0.13M | 0.10M | 0.06M | 0.06M | |||||||
| Total Current Liabilities | 0.01M | 0.06M | 0.04M | 0.04M | 0.24M | 2.79M | 3.38M | 3.42M | 3.52M | 3.63M | 3.78M | 3.93M | 3.93M | 4.07M | 3.99M | |||
| Non-Current Liabilities | ||||||||||||||||||
| Non-Current Debt | 0.20M | 0.20M | 0.20M | 0.20M | 0.20M | 0.53M | 1.00M | 1.10M | 1.16M | 1.14M | 1.14M | 1.15M | 1.23M | 1.19M | 1.14M | |||
| Other Non-Current Liabilities | 0.06M | |||||||||||||||||
| Total Non-Current Liabilities | 0.15M | |||||||||||||||||
| Total Liabilities | 0.21M | 0.10M | 0.21M | 0.20M | 0.26M | 0.23M | 0.24M | 0.24M | 2.94M | 3.53M | 3.67M | 3.80M | 3.89M | 4.04M | 4.81M | 4.81M | 4.95M | 4.87M |
| Shareholder's Equity | ||||||||||||||||||
| Total Debt | 0.20M | 0.25M | 0.22M | 0.22M | 0.41M | 1.43M | 2.81M | 1.95M | 2.03M | 3.16M | 3.16M | 2.12M | 2.27M | 2.36M | 2.26M | |||
| Common Equity | -0.08M | -0.10M | -0.21M | -0.20M | -2.53M | -2.42M | -2.58M | -2.80M | -2.07M | 15.09M | 14.22M | 13.56M | -3.38M | -3.56M | -3.65M | -3.65M | -4.54M | -4.53M |
| Liabilities and Shareholders Equity | 0.13M | 0.06M | 0.08M | 0.09M | 0.03M | 0.87M | 18.62M | 17.89M | 17.36M | 0.51M | 0.48M | 1.15M | 1.17M | 0.41M | 0.34M | |||
| Retained Earnings | -2.80M | -2.92M | -3.44M | -3.44M | -3.49M | -12.52M | 29.80M | 30.04M | 29.78M | -35.57M | -35.84M | -36.02M | -36.10M | -37.12M | -37.14M | |||
| Preferred Shares | 0.01M | 0.01M | 0.01M | 0.01M | 0.01M | 4.00 | 4.00 | 4.00 | 4.00 | 4.00 | 4.00 | 4.00 | 4.00 | 4.00 | 4.00 |
Pull Bioregenx's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/statements?ticker=BRGX&statement=BS&frequency=Quarter&period=all&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/statements"
params = {"ticker": "BRGX", "statement": "BS", "frequency": "Quarter", "period": "all", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/statements?ticker=BRGX&statement=BS&frequency=Quarter&period=all&api_key=YOUR_API_KEY");
const data = await res.json();